Trade Gerresheimer AG - GXI
Gerresheimer AG (ETR: GXI) is a German healthcare packaging and drug delivery company offering glass and plastic vials, syringes, inhalers, and diagnostics components to global pharma and biotech clients. With manufacturing across Europe, the Americas, and Asia, Gerresheimer plays a vital role in regulated drug delivery supply chains. The company is expanding its high-value solutions and biologics-focused offerings. Gerresheimer offers investors a stable, defensive healthcare supplier with embedded growth from injectable therapies and vaccine delivery.Latest shares articles

US midterms: the end of uncertainty could give Wall Street direction
Markets dislike uncertainty and volatility tends to rise ahead of the vote, but once the results are known, indices may be able to set a clearer direction.
13:28, 29 October 2026

BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026

TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026

Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Related News
Public Technologies
Public Technologies
Public Technologies